Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
79.6K
-
Shares change
-
-13.2K
-
Total reported value, excl. options
-
$11.2M
-
Value change
-
-$1.82M
-
Number of buys
-
2
-
Number of sells
-
-4
-
Price
-
$140.38
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2025
9 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q3 2025.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.6K shares
of 99.6M outstanding shares and own 0.08% of the company stock.
Largest 9 shareholders include Assenagon Asset Management S.A. (46.9K shares), Red Spruce Capital, LLC (17.4K shares), WOODSTOCK CORP (7.19K shares), PRAXIS INVESTMENT MANAGEMENT INC (2.8K shares), GAMMA Investing LLC (2.69K shares), Central Pacific Bank - Trust Division (1.73K shares), 1620 INVESTMENT ADVISORS, INC. (911 shares), City Center Advisors, LLC (0 shares), and GFG Capital, LLC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.